5.8
Phase II Reactions: Glucuronidation
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread…
Glucuronidation, a key phase II biotransformation reaction, involves the conjugation of glucuronic acid to xenobiotics or metabolites.
This process is abundant in body tissues and employs D-glucuronic acid, derived endogenously from D-glucose. D-glucuronic acid forms conjugates with diverse functional groups.
The enzymes catalyzing this reaction, called UGTs, are closely associated with the microsomal mixed-function oxidases.
Glucuronide formation is initiated by the synthesis of an activated coenzyme, followed by the transfer of a glucuronyl moiety to the substrate.
O-glucuronides form when glucuronic acid binds to oxygen in the substrate's carboxylic acid or hydroxyl group.
N-glucuronides form when glucuronic acid is attached to nitrogen in amine, amide, or sulfonamide-containing drugs.
S- and C-glucuronides form when the glucuronyl moiety is linked to a thiolic sulfur and nucleophilic carbon, respectively.
These reactions significantly enhance drug hydrophilicity, aiding detoxification and facilitating excretion.
View the full transcript and gain access to JoVE Core videos
Q1: What is glucuronidation and why is it important in drug metabolism?
Glucuronidation is a phase II biotransformation reaction that conjugates glucuronic acid to drugs or xenobiotics, making them more water-soluble and easier to excrete. This process is considered the most crucial phase II reaction because it significantly enhances drug hydrophilicity, facilitating detoxification and urinary elimination. UDP-glucuronosyltransferases (UGTs) are the enzymes that catalyze this essential metabolic pathway.
Q2: How do UDP-glucuronosyltransferases catalyze glucuronide formation?
UGT enzymes bind to both the substrate and UDP-glucuronic acid, then transfer the glucuronic acid moiety to a functional group on the substrate. This activated coenzyme mechanism produces a glucuronide conjugate that is more polar and readily excreted by the kidneys. The reaction requires the synthesis of an activated coenzyme before the glucuronyl transfer occurs.
Q3: What are the different types of glucuronides formed during conjugation?
Glucuronides are classified by their conjugation site: O-glucuronides form when glucuronic acid binds to oxygen in hydroxyl or carboxylic acid groups; N-glucuronides form with nitrogen in amine, amide, or sulfonamide groups; S-glucuronides form with thiolic sulfur; and C-glucuronides form with nucleophilic carbon. Each type results from the glucuronyl moiety attaching to different functional groups on the substrate.
Q4: Which common drugs undergo glucuronidation as a major metabolic pathway?
Acetaminophen, morphine, and ibuprofen are commonly metabolized via glucuronidation. Acetaminophen is converted to a glucuronide conjugate before urinary excretion, morphine transforms into morphine-3-glucuronide, and ibuprofen becomes an inactive glucuronide conjugate. Antidepressants like amitriptyline and HIV medications such as raltegravir also undergo this phase II reaction.
Q5: How does glucuronidation enhance drug elimination from the body?
Glucuronidation increases drug polarity by adding a hydrophilic glucuronic acid moiety, transforming lipophilic compounds into water-soluble metabolites. These polar glucuronide conjugates are rapidly recognized and excreted by the kidneys, preventing drug accumulation and reducing potential toxicity. The enhanced hydrophilicity is the key mechanism enabling efficient renal elimination.
Q6: Where in the body does glucuronidation occur most abundantly?
Glucuronidation is abundant in body tissues and is closely associated with microsomal mixed-function oxidases. The process employs D-glucuronic acid derived endogenously from D-glucose, making it a widespread metabolic capability. This abundance across tissues ensures that glucuronidation can process diverse xenobiotics and drug metabolites efficiently.
Q7: How does glucuronidation relate to other phase II conjugation reactions?
Glucuronidation is one of several phase II conjugation reactions that modify drugs to enhance excretion. While other phase II reactions include phase II reactions glutathione conjugation and mercapturic acid formation and phase reactions sulfation and conjugation with amino acids, glucuronidation is considered the most important due to its widespread occurrence and capacity to metabolize drugs across multiple therapeutic classes.